Viral hepatitis
MONDO:0006011An acute or chronic inflammation of the liver parenchyma caused by viruses. Representative examples include hepatitis A, B, and C, cytomegalovirus hepatitis, and herpes simplex hepatitis.
Also known as: Hepatitis viral, Viruses caused hepatitis, Viruses hepatitis, viral Hepatitis, viral human hepatitis, unspecified viral hepatitis with hepatic coma, viral hepatitis with hepatic coma
446 clinical trials for this condition and its sub-types, 12 tagged with Viral hepatitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Viral hepatitis
-
Hepatitis B virus infection 251 trials · 274 incl. sub-types
2 sub-types
- Chronic hepatitis B virus infection 171 trials
- Acute hepatitis B virus infection 2 trials
-
Hepatitis C virus infection 158 trials · 162 incl. sub-types
2 sub-types
- Chronic hepatitis C virus infection 43 trials
- Acute hepatitis C virus infection 0 trials
-
Hepatitis D virus infection 47 trials
-
Hepatitis A virus infection 10 trials
-
Hepatitis E virus infection 5 trials
-
Epstein-Barr virus hepatitis 0 trials
-
New shot aims to cure hepatitis b – early trial underway
Disease control Recruiting nowThis Phase 2 trial tests an experimental drug called AHB-137 in 84 adults with chronic hepatitis B who are already on antiviral therapy. The goal is to see if AHB-137 can clear the hepatitis B surface antigen and keep the virus under control, potentially leading to a functional c…
Phase 2 • Sponsor: AusperBio Therapeutics Inc. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New shot aims to tame hepatitis b without daily pills
Disease control Recruiting nowThis phase 2 trial tests an experimental drug called AHB-137 in 70 adults with chronic hepatitis B who are already on antiviral pills. The drug is given as a shot under the skin. The goal is to see if it can lower the virus to undetectable levels and allow some people to stop the…
Phase 2 • Sponsor: AusperBio Therapeutics Inc. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Hepatitis b drug showdown: which is safer for kidneys?
Disease control Recruiting nowThis study compares two antiviral drugs, tenofovir alafenamide (TAF) and entecavir, in 140 adults with chronic hepatitis B. The goal is to see which one controls the virus better and causes fewer kidney problems. Participants take one pill daily for about a year.
Phase 4 • Sponsor: Taichung Veterans General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC